Efficacy of inhaled corticosteroids administered once daily for asthma

Timothy Self, Roya M. Sameri

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Inhaled corticosteroids (ICS) are the most effective medications for the long term control of asthma. When first used in asthma management, these drugs were scheduled 3- or 4- times daily, but by the late 1980s, it became clear that most patients respond excellently to twice-daily dosing. Numerous recent double-blind, randomized trials have demonstrated the efficacy of once-daily ICS in the management of pediatric and adult asthma. Once-daily dose ICS is most appropriate for patients' mild persistent asthma, and will be effective for many patients with moderate persistent asthma. Some studies suggest late afternoon/early evening dosing is preferable to single daily dosing in the morning.

Original languageEnglish (US)
Pages (from-to)91-99
Number of pages9
JournalAmerican Journal of Managed Care
Volume9
Issue number1
StatePublished - Jan 1 2003

Fingerprint

Adrenal Cortex Hormones
Asthma
management
medication
drug
Pediatrics
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Health Policy

Cite this

Efficacy of inhaled corticosteroids administered once daily for asthma. / Self, Timothy; Sameri, Roya M.

In: American Journal of Managed Care, Vol. 9, No. 1, 01.01.2003, p. 91-99.

Research output: Contribution to journalReview article

Self, Timothy ; Sameri, Roya M. / Efficacy of inhaled corticosteroids administered once daily for asthma. In: American Journal of Managed Care. 2003 ; Vol. 9, No. 1. pp. 91-99.
@article{16d390c7f9654db19b40bc12f8dc661c,
title = "Efficacy of inhaled corticosteroids administered once daily for asthma",
abstract = "Inhaled corticosteroids (ICS) are the most effective medications for the long term control of asthma. When first used in asthma management, these drugs were scheduled 3- or 4- times daily, but by the late 1980s, it became clear that most patients respond excellently to twice-daily dosing. Numerous recent double-blind, randomized trials have demonstrated the efficacy of once-daily ICS in the management of pediatric and adult asthma. Once-daily dose ICS is most appropriate for patients' mild persistent asthma, and will be effective for many patients with moderate persistent asthma. Some studies suggest late afternoon/early evening dosing is preferable to single daily dosing in the morning.",
author = "Timothy Self and Sameri, {Roya M.}",
year = "2003",
month = "1",
day = "1",
language = "English (US)",
volume = "9",
pages = "91--99",
journal = "American Journal of Managed Care",
issn = "1088-0224",
publisher = "Ascend Media",
number = "1",

}

TY - JOUR

T1 - Efficacy of inhaled corticosteroids administered once daily for asthma

AU - Self, Timothy

AU - Sameri, Roya M.

PY - 2003/1/1

Y1 - 2003/1/1

N2 - Inhaled corticosteroids (ICS) are the most effective medications for the long term control of asthma. When first used in asthma management, these drugs were scheduled 3- or 4- times daily, but by the late 1980s, it became clear that most patients respond excellently to twice-daily dosing. Numerous recent double-blind, randomized trials have demonstrated the efficacy of once-daily ICS in the management of pediatric and adult asthma. Once-daily dose ICS is most appropriate for patients' mild persistent asthma, and will be effective for many patients with moderate persistent asthma. Some studies suggest late afternoon/early evening dosing is preferable to single daily dosing in the morning.

AB - Inhaled corticosteroids (ICS) are the most effective medications for the long term control of asthma. When first used in asthma management, these drugs were scheduled 3- or 4- times daily, but by the late 1980s, it became clear that most patients respond excellently to twice-daily dosing. Numerous recent double-blind, randomized trials have demonstrated the efficacy of once-daily ICS in the management of pediatric and adult asthma. Once-daily dose ICS is most appropriate for patients' mild persistent asthma, and will be effective for many patients with moderate persistent asthma. Some studies suggest late afternoon/early evening dosing is preferable to single daily dosing in the morning.

UR - http://www.scopus.com/inward/record.url?scp=0037270113&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037270113&partnerID=8YFLogxK

M3 - Review article

C2 - 12549817

AN - SCOPUS:0037270113

VL - 9

SP - 91

EP - 99

JO - American Journal of Managed Care

JF - American Journal of Managed Care

SN - 1088-0224

IS - 1

ER -